NCT06660407 2026-03-16
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
20 trialsNCT05271630 2026-03-02
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
H. Lee Moffitt Cancer Center and Research Institute
Active not recruiting
NCT04150939 2026-02-17
Cryoablation for the Treatment of Metastatic Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04594187 2026-02-17
MelPORT
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04151940 2026-01-14
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
University of Washington
Phase NA Recruiting
NCT05307835 2025-12-02
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Active not recruiting
NCT04926948 2025-10-22
Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma
Mayo Clinic
Phase 1 Active not recruiting
NCT03978039 2025-09-04
BCB-Sarcomes
Institut Bergonié
Recruiting
NCT02276443 2025-08-01
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06130826 2025-05-30
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT05178472 2025-03-17
Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT02949843 2024-06-28
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Wake Forest University Health Sciences
Phase 2 Terminated
NCT05950113 2024-05-01
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Jonsson Comprehensive Cancer Center
Phase 1 Withdrawn
NCT03835520 2023-12-11
Plasma-Target
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase NA Active not recruiting
NCT04810910 2021-11-16
Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Zhejiang Provincial People's Hospital
Phase 1 Unknown
NCT04864379 2021-04-28
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
Sir Run Run Shaw Hospital
Phase 1 Unknown
NCT02754362 2020-01-13
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
NYU Langone Health
Phase 2 Withdrawn
NCT00365937 2019-03-06
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Terminated
NCT02976740 2016-11-29
SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown
NCT00052403 2014-01-16
Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn